VAL ValiRx plc

0.0018USD0.1400 GBp · LSE-12.50%Mkt Cap: 2.43M USDP/E: —

ValiRx plc, together with its subsidiaries, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company develops VAL401, a reformulation of anti-psychotic drug risperi…

Key Statistics

Company
Market Cap2.43M USD
Enterprise Value-371.56K USD
Revenue (TTM)42.97K USD
Gross Profit-8.22K USD
Net Income (TTM)-2.94M USD
Revenue/Share0.00 USD
Last Price0.0018 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees11
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINGB00BLH13C52
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA0.19
EV/Revenue-8.65
P/S56.58
P/B0.35
EPS (TTM)0.00 USD
EPS (Forward)-2.45 USD
52W Range
0.00166% of range0.0063
52W High0.0063 USD
52W Low0.0016 USD
Profitability
Gross Margin-19.92%
Oper. Margin-5233.68%
EBITDA Margin0.00%
Profit Margin-7115.13%
ROE-78.18%
ROA-84.82%
ROIC-107.52%
ROCE-76.05%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.99M USD
CapEx (TTM)17.86K USD
FCF Margin-2592.20%
FCF Yield-45.82%
Net Debt-1.28M USD
Net Debt/EBITDA0.65
Net Debt/FCF—
Balance Sheet
Debt/Equity0.00
Current Ratio10.98
Quick Ratio10.41
Book Value/Sh0.0053 USD
Cash/Share0.0013 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:125
Split DateApr 6, 2020
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.32B
Float772.00M
Insiders8.77%
Institutions0.00%
Technical
SMA 500.0019 (-1.5%)
SMA 2000.0027 (-31.8%)
Beta-0.42
S&P 52W Chg8.68%
Avg Vol (30d)29.77M
Avg Vol (10d)16.63M
Technical Indicators
RSI (14)46.0
MACD0.0014
MACD Signal0.0030
MACD Hist.-0.0016
BB Upper0.0024 USD
BB Middle0.0020 USD
BB Lower0.0017 USD
BB Width34.37%
ATR (14)0.0003 USD
Vol Ratio (20d)1.64x

About ValiRx (LON: VAL)

›

ValiRx (LON: VAL) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 11 employees.

The shares were at 0.1400 GBp on 20 November 2026, down 40.4% over 52 weeks. Its 52-week range is 0.1200 GBp to 0.4800 GBp: the price is 70.8% below the high and 16.7% above the low.

Its market capitalisation is 1.85M GBP.

ValiRx reports return on equity of -78.2%.

It holds more cash than debt, a net cash position of 970.56K GBP. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.